Ascendis Pharma A/S (ASND)
USD 163.34
(3.28%)
USD 163.34
(3.28%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -455.54 Million EUR | 18.92% |
| 2022 | -561.81 Million EUR | -24.35% |
| 2021 | -451.79 Million EUR | -36.65% |
| 2020 | -330.62 Million EUR | -45.83% |
| 2019 | -226.71 Million EUR | -46.5% |
| 2018 | -154.75 Million EUR | -38.74% |
| 2017 | -111.54 Million EUR | -52.96% |
| 2016 | -72.92 Million EUR | -74.35% |
| 2015 | -41.82 Million EUR | -248.86% |
| 2014 | -11.98 Million EUR | -327.11% |
| 2013 | 5.27 Million EUR | 248.91% |
| 2012 | 1.51 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -49.14 Million EUR | -34.24% |
| 2024 Q2 | -133.93 Million EUR | -171.15% |
| 2023 Q4 | -36.61 Million EUR | 72.76% |
| 2023 FY | -455.54 Million EUR | 18.92% |
| 2023 Q1 | -143.68 Million EUR | 2.51% |
| 2023 Q2 | -140.83 Million EUR | 1.98% |
| 2023 Q3 | -134.4 Million EUR | 4.57% |
| 2022 Q4 | -147.38 Million EUR | -1.99% |
| 2022 Q3 | -144.5 Million EUR | -1.84% |
| 2022 Q1 | -128.02 Million EUR | -13.72% |
| 2022 Q2 | -141.89 Million EUR | -10.83% |
| 2022 FY | -561.81 Million EUR | -24.35% |
| 2021 Q3 | -96.93 Million EUR | 17.6% |
| 2021 FY | -451.79 Million EUR | -36.65% |
| 2021 Q2 | -117.62 Million EUR | 5.63% |
| 2021 Q1 | -124.65 Million EUR | -30.33% |
| 2021 Q4 | -112.58 Million EUR | -16.14% |
| 2020 Q3 | -78.82 Million EUR | 4.97% |
| 2020 Q4 | -95.64 Million EUR | -21.34% |
| 2020 FY | -330.62 Million EUR | -45.83% |
| 2020 Q2 | -82.94 Million EUR | -13.31% |
| 2020 Q1 | -73.2 Million EUR | -12.89% |
| 2019 Q1 | -56.28 Million EUR | -56.98% |
| 2019 FY | -226.71 Million EUR | -46.5% |
| 2019 Q4 | -64.84 Million EUR | -20.06% |
| 2019 Q3 | -54.01 Million EUR | -4.73% |
| 2019 Q2 | -51.57 Million EUR | 8.36% |
| 2018 FY | -154.75 Million EUR | -38.74% |
| 2018 Q4 | -35.85 Million EUR | 6.36% |
| 2018 Q2 | -45.44 Million EUR | -29.19% |
| 2018 Q1 | -35.17 Million EUR | -10.47% |
| 2018 Q3 | -38.28 Million EUR | 15.75% |
| 2017 Q3 | -31.47 Million EUR | -27.59% |
| 2017 FY | -111.54 Million EUR | -52.96% |
| 2017 Q1 | -23.56 Million EUR | -5.97% |
| 2017 Q2 | -24.66 Million EUR | -4.69% |
| 2017 Q4 | -31.84 Million EUR | -1.17% |
| 2016 Q4 | -22.23 Million EUR | -23.65% |
| 2016 FY | -72.92 Million EUR | -74.35% |
| 2016 Q1 | -17.89 Million EUR | -27.73% |
| 2016 Q3 | -17.98 Million EUR | -21.4% |
| 2016 Q2 | -14.81 Million EUR | 17.21% |
| 2015 Q1 | -7.65 Million EUR | -8.45% |
| 2015 Q4 | -14 Million EUR | -91.44% |
| 2015 Q3 | -7.31 Million EUR | 43.02% |
| 2015 Q2 | -12.84 Million EUR | -67.69% |
| 2015 FY | -41.82 Million EUR | -248.86% |
| 2014 Q1 | -510 Thousand EUR | -122.36% |
| 2014 Q3 | -2.23 Million EUR | -2.66% |
| 2014 Q2 | -2.18 Million EUR | -327.45% |
| 2014 FY | -11.98 Million EUR | -327.11% |
| 2014 Q4 | -7.06 Million EUR | -215.5% |
| 2013 Q3 | 1.78 Million EUR | 195.13% |
| 2013 Q1 | 605.5 Thousand EUR | 0.0% |
| 2013 FY | 5.27 Million EUR | 248.91% |
| 2013 Q4 | 2.28 Million EUR | 27.64% |
| 2013 Q2 | 605.5 Thousand EUR | 0.0% |
| 2012 FY | 1.51 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Agenus Inc. | -159.54 Million USD | -185.518% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -19.723% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -14306.736% |
| Acelyrin, Inc. | -422.06 Million USD | -7.932% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -935.085% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -592.743% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1279.549% |
| IO Biotech, Inc. | -91.44 Million USD | -398.169% |
| Ardelyx, Inc. | -63.27 Million USD | -619.927% |
| Geron Corporation | -193.94 Million USD | -134.883% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -366.294% |
| Innoviva, Inc. | 176.7 Million USD | 357.792% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5258.675% |
| ChromaDex Corporation | -5.59 Million USD | -8036.114% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 3914.612% |
| Onconetix, Inc. | -36.03 Million USD | -1164.177% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -992.058% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1059.867% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -238.871% |
| Vaxcyte, Inc. | -468.04 Million USD | 2.671% |
| Pharming Group N.V. | -4.87 Million USD | -9235.729% |
| ContextLogic Inc. | -328 Million USD | -38.884% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -6503.958% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -454.213% |
| AlloVir, Inc. | -181.33 Million USD | -151.221% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1774.145% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -246.459% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -3532611.281% |
| Summit Therapeutics Inc. | -89.73 Million USD | -407.646% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1129.066% |
| Senti Biosciences, Inc. | -92.72 Million USD | -391.271% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1229.387% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -16454.141% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -757.467% |
| PDS Biotechnology Corporation | -43.04 Million USD | -958.284% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2497.303% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -569.953% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -172.27% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1430.921% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -371.038% |
| Elevation Oncology, Inc. | -45.44 Million USD | -902.401% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -884.826% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -11455.948% |
| AbCellera Biologics Inc. | -237.2 Million USD | -92.044% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2245.91% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -66.253% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1102.939% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -442.867% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1774.145% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -533.285% |
| ESSA Pharma Inc. | -32.13 Million USD | -1317.625% |
| Vaxxinity, Inc. | -58.28 Million USD | -681.575% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1454.482% |
| Structure Therapeutics Inc. | -102.77 Million USD | -343.241% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -702.588% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -296.906% |
| Lantern Pharma Inc. | -17.87 Million USD | -2448.115% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1456.979% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -4212.61% |
| Opthea Limited | -191.84 Million USD | -137.455% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -93.355% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -253.165% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1246.002% |
| Molecular Templates, Inc. | -10.46 Million USD | -4252.58% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3788.568% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 9.671% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -798.627% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -107.8% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -784.443% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2205.866% |
| Alkermes plc | 414.12 Million USD | 210.002% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -61.439% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -4483.993% |
| AnaptysBio, Inc. | -164.41 Million USD | -177.075% |
| Aptorum Group Limited | -10.52 Million USD | -4228.867% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -122.213% |
| Bicycle Therapeutics plc | -189.94 Million USD | -139.827% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -165.186% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -227.654% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1733.606% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -804.515% |
| Chimerix, Inc. | -93.06 Million USD | -389.487% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 624.744% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -910.577% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -292.508% |
| CRISPR Therapeutics AG | -222.53 Million USD | -104.703% |
| Precision BioSciences, Inc. | -43.73 Million USD | -941.57% |
| Dyadic International, Inc. | -8.22 Million USD | -5435.303% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -38116.527% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -139.115% |
| Fortress Biotech, Inc. | -142.34 Million USD | -220.033% |
| Fortress Biotech, Inc. | -142.34 Million USD | -220.033% |
| GT Biopharma, Inc. | -13.57 Million USD | -3255.488% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -5822.084% |
| ImmuCell Corporation | -5.74 Million USD | -7825.101% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2167.525% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2722.24% |
| Incyte Corporation | 620.52 Million USD | 173.412% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -5375.911% |
| Jaguar Health, Inc. | -34.29 Million USD | -1228.456% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -524.208% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -168.058% |
| MiMedx Group, Inc. | 37.11 Million USD | 1327.344% |
| MEI Pharma, Inc. | 14.54 Million USD | 3232.588% |
| Mesoblast Limited | -58.79 Million USD | -674.809% |
| Novavax, Inc. | -566.51 Million USD | 19.588% |
| NextCure, Inc. | -67.63 Million USD | -573.509% |
| Precigen, Inc. | -88.92 Million USD | -412.287% |
| PureTech Health plc | -146.19 Million USD | -211.59% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2123.127% |
| Seer, Inc. | -103.46 Million USD | -340.294% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -98.101% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -75.438% |
| Aptose Biosciences Inc. | -52.35 Million USD | -770.084% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -3058.922% |
| Soligenix, Inc. | -7.69 Million USD | -5817.7% |
| Century Therapeutics, Inc. | -146.54 Million USD | -210.852% |
| Kura Oncology, Inc. | -165.8 Million USD | -174.747% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -387.429% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -18256.457% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -6925.617% |
| Autolus Therapeutics plc | -195.02 Million USD | -133.577% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -438.102% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -518.421% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2055.387% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -100.648% |
| GRI Bio, Inc. | -11.38 Million USD | -3900.536% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -9987.904% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -247.23% |
| IGM Biosciences, Inc. | -263.46 Million USD | -72.906% |
| INmune Bio, Inc. | -29.74 Million USD | -1431.694% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -311.826% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1096.421% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2750.809% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2788.504% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -645.591% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -323.672% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -65.047% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -124.185% |
| Verastem, Inc. | -92.08 Million USD | -394.702% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -866.46% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -147.382% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -284.812% |
| Histogen Inc. | -10.64 Million USD | -4180.194% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -2844.301% |
| Surrozen, Inc. | -45.78 Million USD | -895.066% |
| Organovo Holdings, Inc. | -15.08 Million USD | -2919.627% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -8849.31% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -668.438% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -788.098% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1701.982% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -5868.169% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -165.958% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -840.269% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -482.496% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -2892.89% |
| Apollomics, Inc. | -54.83 Million USD | -730.764% |
| Amarin Corporation plc | -67.58 Million USD | -573.997% |
| Turnstone Biologics Corp. | -59.03 Million USD | -671.685% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -175.201% |
| Synaptogenix, Inc. | -8.31 Million USD | -5379.3% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -3023.139% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -396.822% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9407.341% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -5058.293% |
| Exelixis, Inc. | 170.88 Million USD | 366.578% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1090.583% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -193.778% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 11.908% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3758.208% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -5564.59% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1418.824% |
| Gritstone bio, Inc. | -154.63 Million USD | -194.593% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -561.537% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2560.396% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2338.917% |
| Insmed Incorporated | -709.62 Million USD | 35.805% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -2803.424% |
| MediWound Ltd. | -15.29 Million USD | -2879.339% |
| OmniAb, Inc. | -69.41 Million USD | -556.219% |
| Alector, Inc. | -151.74 Million USD | -200.212% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -321.864% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -773.554% |
| Zai Lab Limited | -366.57 Million USD | -24.27% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -43.805% |
| Aura Biosciences, Inc. | -84.99 Million USD | -435.987% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -85.557% |
| Immunic, Inc. | -99.22 Million USD | -359.108% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -218.209% |
| Veracyte, Inc. | -85.79 Million USD | -430.965% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -61.645% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3105.778% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -6513.596% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2324.042% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 178.734% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1689.734% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1274.014% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2307.827% |
| Galecto, Inc. | -39.9 Million USD | -1041.564% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -982.714% |
| Fortrea Holdings Inc. | 63.1 Million USD | 821.935% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -224.355% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1477.467% |
| XBiotech Inc. | -37.51 Million USD | -1114.452% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -561.537% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -578.696% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -322.165% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1674.466% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -754.802% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 19.969% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -480.366% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -339.249% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1947.087% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -427.149% |
| NexImmune, Inc. | -29.19 Million USD | -1460.474% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -8005.521% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -3024.129% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 111.256% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1689.312% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -258.519% |
| Ainos, Inc. | -13.2 Million USD | -3349.397% |
| Pluri Inc. | -22.15 Million USD | -1955.876% |
| Prothena Corporation plc | -191.03 Million USD | -138.458% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -230.011% |
| Celularity Inc. | -192.28 Million USD | -136.907% |
| Rallybio Corporation | -78.93 Million USD | -477.131% |
| Cue Biopharma, Inc. | -52.14 Million USD | -773.537% |
| MeiraGTx Holdings plc | -137.06 Million USD | -232.364% |
| Omeros Corporation | -164.53 Million USD | -176.874% |
| Humacyte, Inc. | -100.04 Million USD | -355.327% |
| Immunocore Holdings plc | -59.64 Million USD | -663.703% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2354.556% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1760.642% |
| Blueprint Medicines Corporation | -486.27 Million USD | 6.321% |
| CalciMedica, Inc. | -21.87 Million USD | -1982.473% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -510.154% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -165.939% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -39.352% |
| Pulmatrix, Inc. | -14.74 Million USD | -2990.509% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1174.419% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -412.616% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 11.595% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -574.366% |
| Cytokinetics, Incorporated | -496.2 Million USD | 8.195% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1223.516% |
| Nutriband Inc. | -4.87 Million USD | -9250.327% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -944.507% |
| Vor Biopharma Inc. | -126.03 Million USD | -261.437% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 110.739% |
| Evogene Ltd. | -26.39 Million USD | -1626.123% |
| ProKidney Corp. | -151.52 Million USD | -200.643% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -605.882% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 24.998% |
| CorMedix Inc. | -48.95 Million USD | -830.477% |
| BioLineRx Ltd. | -49.69 Million USD | -816.692% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -298.992% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1096.525% |
| Atai Life Sciences N.V. | -125.47 Million USD | -263.065% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -457.992% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -459.571% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -82.957% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1381.916% |
| MediciNova, Inc. | -9.9 Million USD | -4501.301% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -260.473% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6189.866% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1603.407% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -96.502% |
| Biomea Fusion, Inc. | -126.13 Million USD | -261.154% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -30.377% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1503.114% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -138.392% |
| Absci Corporation | -115.51 Million USD | -294.357% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1551.289% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -303.609% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -88.114% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1707.989% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -119.016% |
| Allakos Inc. | -196.05 Million USD | -132.352% |
| Imunon, Inc. | -21.03 Million USD | -2066.104% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -311.643% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 524.62% |
| BioAtla, Inc. | -129.68 Million USD | -251.262% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3758.208% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -2775.346% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -38.996% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -990.907% |
| XOMA Corporation | -41.84 Million USD | -988.561% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -332.872% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -274.946% |
| aTyr Pharma, Inc. | -54.91 Million USD | -729.478% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -421.053% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -163.517% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -79.03% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2022.151% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -5446.75% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2610.586% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5151313.034% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 234.946% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -6871.831% |
| UroGen Pharma Ltd. | -65.53 Million USD | -595.1% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -410.25% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -6172.067% |
| Orgenesis Inc. | -53.63 Million USD | -749.319% |
| Entera Bio Ltd. | -8.89 Million USD | -5023.619% |
| GH Research PLC | -41.22 Million USD | -1005.092% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1671.981% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -448.494% |
| Xencor, Inc. | -138.63 Million USD | -228.581% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -8737.592% |
| Replimune Group, Inc. | -234.77 Million USD | -94.035% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2019.671% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -3165.059% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -6871.831% |
| Portage Biotech Inc. | -18.25 Million USD | -2395.705% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6189.866% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -334.01% |
| OncoCyte Corporation | -25.13 Million USD | -1712.305% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3929.604% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3876.072% |
| Purple Biotech Ltd. | 22.27 Million USD | 2145.445% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -5964.177% |
| scPharmaceuticals Inc. | -55.39 Million USD | -722.336% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2310.564% |
| HilleVax, Inc. | -133.34 Million USD | -241.626% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -3680.737% |
| Tharimmune, Inc. | -9.45 Million USD | -4717.878% |
| Genprex, Inc. | -31.07 Million USD | -1365.914% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -142.059% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1351.831% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -59447.843% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -8263.278% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2892273.393% |
| Savara Inc. | -60 Million USD | -659.146% |
| Curis, Inc. | -48.33 Million USD | -842.525% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1377.117% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -8631.389% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -6160.011% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1571.71% |
| BeiGene, Ltd. | -1.2 Billion USD | 62.281% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2184.639% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 6.495% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -386.419% |
| Erasca, Inc. | -141.52 Million USD | -221.88% |
| bluebird bio, Inc. | -244.26 Million USD | -86.497% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -9962.815% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 334.282% |
| DBV Technologies S.A. | -76.43 Million USD | -496.008% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -9962.815% |
| Moderna, Inc. | -4.23 Billion USD | 89.254% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -969.119% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -7062.594% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -577.515% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -20.915% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -217.869% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -776.158% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -194.768% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -118.873% |
| MacroGenics, Inc. | -168.24 Million USD | -170.762% |
| RenovoRx, Inc. | -11.39 Million USD | -3897.376% |
| Adicet Bio, Inc. | -152.03 Million USD | -199.623% |
| Prime Medicine, Inc. | -191.29 Million USD | -138.139% |
| Aditxt, Inc. | -26.06 Million USD | -1647.884% |
| Adagene Inc. | -23.71 Million USD | -1820.504% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6131.667% |
| Quantum-Si incorporated | -111.17 Million USD | -309.766% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1339.399% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3024.902% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 473.351% |
| SciSparc Ltd. | -5.77 Million USD | -7790.889% |
| Vericel Corporation | -6.46 Million USD | -6947.355% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5162.316% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1870.369% |
| Generation Bio Co. | -138.56 Million USD | -228.761% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -448.646% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -426.881% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -88.942% |
| Invivyd, Inc. | -207.78 Million USD | -119.239% |
| Relay Therapeutics, Inc. | -373 Million USD | -22.129% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -4757.289% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2220.669% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4328.317% |
| 2seventy bio, Inc. | -216.7 Million USD | -110.214% |
| Clene Inc. | -40.54 Million USD | -1023.683% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1791.95% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -731.34% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1603.407% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -30.132% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1140.174% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 2933.495% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -339.279% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1239.748% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -167.528% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 33.43% |
| Evaxion Biotech A/S | -22.19 Million USD | -1952.264% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -452.962% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -104.165% |
| Trevena, Inc. | -35.28 Million USD | -1190.923% |
| Surrozen, Inc. | -45.78 Million USD | -895.066% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -469.818% |
| Cingulate Inc. | -22.75 Million USD | -1901.569% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 6180.366% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -919.86% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -5432.478% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -344.179% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -520.806% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -633.868% |
| Clearmind Medicine Inc. | -8.74 Million USD | -5111.335% |
| Kronos Bio, Inc. | -121.83 Million USD | -273.915% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -497.854% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -15431.651% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -351.805% |
| Statera Biopharma, Inc. | -98.34 Million USD | -363.213% |
| ImmunityBio, Inc. | -362.25 Million USD | -25.753% |
| Korro Bio, Inc. | -84.53 Million USD | -438.885% |
| Kineta, Inc. | -15.72 Million USD | -2797.291% |
| BioVie Inc. | -32.17 Million USD | -1315.621% |
| Codexis, Inc. | -68.06 Million USD | -569.234% |
| Celularity Inc. | -192.28 Million USD | -136.907% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -104.638% |
| Celcuity Inc. | -66.23 Million USD | -587.813% |
| Virax Biolabs Group Limited | -6.49 Million USD | -6912.128% |
| Cibus, Inc. | -318.88 Million USD | -42.855% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -959.398% |
| IN8bio, Inc. | -30.33 Million USD | -1401.602% |
| Kodiak Sciences Inc. | -277.32 Million USD | -64.265% |
| Annexon, Inc. | -143.72 Million USD | -216.958% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -267.992% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -604.67% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1843.103% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -28.782% |
| Eyenovia, Inc. | -25.4 Million USD | -1693.013% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1495.653% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8090.237% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -475.665% |
| Arcellx, Inc. | -89.88 Million USD | -406.832% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -903.129% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -232.01% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1364.338% |
| Moolec Science SA | -6.65 Million USD | -6746.323% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -645.103% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -953.201% |
| Royalty Pharma plc | 1.49 Billion USD | 130.529% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -177.495% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4783.657% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1980.603% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -166.465% |
| Humacyte, Inc. | -100.04 Million USD | -355.327% |
| 89bio, Inc. | -151.2 Million USD | -201.276% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -468.488% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -3033.019% |
| Genelux Corporation | -24.16 Million USD | -1785.127% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1242.868% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -165.235% |
| Notable Labs, Ltd. | -14.65 Million USD | -3008.01% |
| Liquidia Corporation | -73.38 Million USD | -520.763% |
| Mustang Bio, Inc. | -50.72 Million USD | -798.042% |
| Immunovant, Inc. | -282.7 Million USD | -61.134% |
| Quantum-Si incorporated | -111.17 Million USD | -309.766% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -483.257% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2042.009% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -346.556% |
| Acasti Pharma Inc. | -11.31 Million USD | -3927.06% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1887.43% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2750.809% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -112.816% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -12315.701% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2767.563% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1462.373% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1000.766% |
| PepGen Inc. | -84.76 Million USD | -437.41% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1437.38% |
| United Therapeutics Corporation | 1.18 Billion USD | 138.446% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1889.523% |
| Solid Biosciences Inc. | -104.31 Million USD | -336.698% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1288.501% |
| Immuneering Corporation | -58.41 Million USD | -679.864% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -8849.31% |
| Silo Pharma, Inc. | -3.85 Million USD | -11715.073% |
| Belite Bio, Inc | -31.66 Million USD | -1338.49% |
| XOMA Corporation | -41.84 Million USD | -988.561% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -574.676% |
| Bionomics Limited | -17.89 Billion USD | 97.454% |
| Apogee Therapeutics, Inc. | -93 Million USD | -389.813% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1376.74% |
| uniQure N.V. | -282.87 Million USD | -61.042% |
| Cassava Sciences, Inc. | -105.95 Million USD | -329.93% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6131.667% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -251.758% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1302.269% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -5382.663% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1449.723% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8090.237% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3105.778% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -5024.772% |
| Altimmune, Inc. | -95.92 Million USD | -374.873% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -519.834% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1376.74% |
| Compugen Ltd. | -12.99 Million USD | -3406.319% |
| Peak Bio, Inc. | -1356.23 USD | -33588671.816% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -818.355% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1925.527% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -88.005% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1431.436% |
| Zura Bio Limited | -62.63 Million USD | -627.26% |
| PolyPid Ltd. | -22.86 Million USD | -1892.133% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2698.851% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1431.436% |
| Instil Bio, Inc. | -159.16 Million USD | -186.2% |
| argenx SE | -425.04 Million USD | -7.174% |
| Immunome, Inc. | -109.53 Million USD | -315.905% |
| Verona Pharma plc | -67.83 Million USD | -571.583% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1648.047% |
| Shattuck Labs, Inc. | -91.95 Million USD | -395.385% |
| CervoMed Inc. | -7.81 Million USD | -5730.63% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -523.09% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -3319.721% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -845.616% |
| Moolec Science SA | -6.65 Million USD | -6746.323% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2669.509% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -236.872% |
| Design Therapeutics, Inc. | -78.19 Million USD | -482.608% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -423.364% |
| NeurAxis, Inc. | -6.66 Million USD | -6735.342% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1024.82% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1144.172% |
| Achilles Therapeutics plc | -75.25 Million USD | -505.33% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1648.047% |
| 180 Life Sciences Corp. | -13.47 Million USD | -3280.011% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 8934.63% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -15431.651% |
| Nutriband Inc. | -4.87 Million USD | -9250.327% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -311.212% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -721.55% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -796.099% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -589.18% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -741.676% |
| Palisade Bio, Inc. | -13.07 Million USD | -3385.394% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -903.195% |
| Beam Therapeutics Inc. | -176.48 Million USD | -158.119% |
| Neurogene Inc. | -55.58 Million USD | -719.569% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -317.338% |
| AEON Biopharma, Inc. | -48.42 Million USD | -840.637% |
| Sesen Bio, Inc. | -25.9 Million USD | -1658.235% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -445.369% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -3519.169% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 1.09% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -528.862% |
| Athira Pharma, Inc. | -125.46 Million USD | -263.079% |
| Vaccinex, Inc. | -22.88 Million USD | -1890.566% |
| HCW Biologics Inc. | -25.71 Million USD | -1671.35% |
| XOMA Corporation | -41.84 Million USD | -988.561% |
| Nektar Therapeutics | -137.42 Million USD | -231.483% |
| Arvinas, Inc. | -401.5 Million USD | -13.46% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5151313.034% |
| Merus N.V. | -156.54 Million USD | -190.993% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -354.355% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1215.832% |
| Rezolute, Inc. | -70.42 Million USD | -546.864% |
| Clene Inc. | -40.54 Million USD | -1023.683% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2681.34% |
| BeyondSpring Inc. | -23.11 Million USD | -1870.845% |
| Synlogic, Inc. | -55.16 Million USD | -725.839% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2440.805% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4108.62% |
| Peak Bio, Inc. | -1356.23 USD | -33588671.816% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1024.709% |
| Krystal Biotech, Inc. | -109.72 Million USD | -315.159% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -251.66% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -32.806% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -9498.515% |
| MannKind Corporation | 8.67 Million USD | 5349.378% |
| Ikena Oncology, Inc. | -75.41 Million USD | -504.03% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -4622.1% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -577.586% |
| Gossamer Bio, Inc. | -183.75 Million USD | -147.901% |
| CohBar, Inc. | -12.38 Million USD | -3577.188% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -798.078% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1551.289% |
| Legend Biotech Corporation | -439.48 Million USD | -3.653% |
| Mural Oncology plc | -194.63 Million USD | -134.045% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -578.464% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2721.514% |
| Disc Medicine, Inc. | -91.12 Million USD | -399.908% |
| Champions Oncology, Inc. | -7.35 Million USD | -6092.781% |
| REGENXBIO Inc. | -268.12 Million USD | -69.897% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4150.168% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -717.026% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1069.234% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -298.35% |
| Vaxart, Inc. | -83.34 Million USD | -446.56% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -5246.72% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -964.495% |
| Cellectis S.A. | -106.62 Million USD | -327.233% |
| Longeveron Inc. | -21.02 Million USD | -2066.251% |
| Repare Therapeutics Inc. | -116.22 Million USD | -291.951% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -70.09% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -502.209% |
| Revolution Medicines, Inc. | -487.18 Million USD | 6.495% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -6748.181% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -936.404% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -510.727% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -554.184% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -4037.145% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 110.576% |
| Denali Therapeutics Inc. | -196.69 Million USD | -131.593% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5162.316% |
| Veru Inc. | -93.78 Million USD | -385.743% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1852.681% |
| Cingulate Inc. | -22.75 Million USD | -1901.569% |
| Passage Bio, Inc. | -108.38 Million USD | -320.283% |
| Context Therapeutics Inc. | -25.07 Million USD | -1716.887% |
| Exicure, Inc. | -14.99 Million USD | -2937.75% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -121.068% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1022.077% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -4588.113% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -147.097% |
| Nuvalent, Inc. | -149.49 Million USD | -204.726% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -5444.216% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -413.396% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2092.842% |
| OmniAb, Inc. | -69.41 Million USD | -556.219% |
| Anew Medical, Inc. | -1.3 Million USD | -34918.988% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -3466.996% |
| Lipocine Inc. | -17.93 Million USD | -2440.528% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -564.897% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -498.2% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1096.421% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1052.481% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1935.119% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 21.438% |
| Ocugen, Inc. | -65.53 Million USD | -595.153% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -385.31% |
| Q32 Bio Inc. | -92.1 Million USD | -394.605% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2024.824% |
| Alumis Inc. Common Stock | -158.17 Million USD | -188.0% |
| Equillium, Inc. | -14.52 Million USD | -3036.903% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -629.963% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -5663.898% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2314.728% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -870.248% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -319.985% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -3705.684% |
| Dominari Holdings Inc. | -21.79 Million USD | -1990.021% |
| Edesa Biotech, Inc. | -9.22 Million USD | -4839.314% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1686.295% |
| Bio-Techne Corporation | 206.68 Million USD | 320.402% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -16.362% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 337.224% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -244.384% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1086.583% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -201.481% |
| Nkarta, Inc. | -131.65 Million USD | -246.024% |
| BioCardia, Inc. | -11.64 Million USD | -3812.238% |
| Iterum Therapeutics plc | -47.46 Million USD | -859.68% |